• Mon, February 26, 2024
David Nierengarten Maintained (SWTX) at Buy with Increased Target to $70 on, Feb 26th, 2024
David Nierengarten of Wedbush, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Increased Target from $60 to $70 on, Feb 26th, 2024.
David has made no other calls on SWTX in the last 4 months.
There are 3 other peers that have a rating on SWTX. Out of the 3 peers that are also analyzing SWTX, 0 agree with David's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with David
- Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $47 on, Thursday, January 25th, 2024
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $73 on, Wednesday, November 29th, 2023
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $52 on, Wednesday, November 29th, 2023
Like: 👍
